APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pemetrexed Disodium for Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pemetrexed Disodium for Injection Market Analysis and Forecast 2026-2032

Report ID 174023250222 December 2025213 pages

Choose your research edition.

Industry ResearchPemetrexed Disodium for Injection Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemetrexed Disodium for Injection Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Pemetrexed Disodium for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemetrexed Disodium for Injection Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemetrexed Disodium for Injection Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Pemetrexed Disodium for Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pemetrexed Disodium for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pemetrexed Disodium for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pemetrexed Disodium for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pemetrexed Disodium for Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pemetrexed Disodium for Injection include Accord Healthcare, Amneal Pharmaceuticals, APOTEX, Biocon, Dr. Reddy's Laboratories, Eugia Pharma, Nang Kuang Pharmaceutical, Pfizer (Hospira) and Waverley Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pemetrexed Disodium for Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pemetrexed Disodium for Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Pemetrexed Disodium for Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pemetrexed Disodium for Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pemetrexed Disodium for Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pemetrexed Disodium for Injection sales, projected growth trends, production technology, application and end-user industry.

Pemetrexed Disodium for Injection Segment by Company

Accord Healthcare

Amneal Pharmaceuticals

APOTEX

Biocon

Dr. Reddy's Laboratories

Eugia Pharma

Nang Kuang Pharmaceutical

Pfizer (Hospira)

Waverley Pharma

Zydus Lifesciences

Baxter

Beijing Xiehe Pharmaceutical

Dezhou Deyao Pharmaceutical

Fresenius Kabi

Hainan Jinrui Pharmaceutical

Kelun Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Qilu Pharmaceutical

Lilly

Lianyungang Jaripharm Pharmaceutical

Nanjing Pharmaceutical Factory

Jiangsu Hansoh Pharmaceutical

Sandoz

Zhendong Group

Shanghai Chemo Wanbang Biopharma

Sichuan Huiyu Pharmaceutical

Suzhou Erye Pharmaceutical

Suzhou Thery Pharmaceutical

Jiangsu Simcere Pharmaceutical

Yangtze River Pharmaceutical Group

Pemetrexed Disodium for Injection Segment by Type

500mg/Pcs

100mg/Pcs

Pemetrexed Disodium for Injection Segment by Application

Hospitals

Clinics

Others

Pemetrexed Disodium for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Disodium for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Disodium for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Disodium for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pemetrexed Disodium for Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pemetrexed Disodium for Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pemetrexed Disodium for Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pemetrexed Disodium for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 500mg/Pcs Major Manufacturers Table 3. 100mg/Pcs Major Manufacturers Table 4. Global Pemetrexed Disodium for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Clinics Major Manufacturers Table 7. Others Major Manufacturers Table 8. Pemetrexed Disodium for Injection Industry Trends Table 9. Pemetrexed Disodium for Injection Industry Drivers Table 10. Pemetrexed Disodium for Injection Industry Opportunities and Challenges Table 11. Pemetrexed Disodium for Injection Industry Restraints Table 12. Global Pemetrexed Disodium for Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Pemetrexed Disodium for Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Pemetrexed Disodium for Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2021-2026) Table 16. Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2027-2032) Table 17. Global Pemetrexed Disodium for Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Pemetrexed Disodium for Injection Sales by Region (2021-2026) & (k units) Table 19. Global Pemetrexed Disodium for Injection Sales by Region (2027-2032) & (k units) Table 20. Global Pemetrexed Disodium for Injection Sales Market Share by Region (2021-2026) Table 21. Global Pemetrexed Disodium for Injection Sales Market Share by Region (2027-2032) Table 22. Global Pemetrexed Disodium for Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Pemetrexed Disodium for Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Pemetrexed Disodium for Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Pemetrexed Disodium for Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Pemetrexed Disodium for Injection Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Pemetrexed Disodium for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Pemetrexed Disodium for Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Pemetrexed Disodium for Injection Manufacturers, Product Type & Application Table 30. Global Pemetrexed Disodium for Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Pemetrexed Disodium for Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Pemetrexed Disodium for Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pemetrexed Disodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Pemetrexed Disodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2021-2026) Table 37. Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2027-2032) Table 38. Global Pemetrexed Disodium for Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 40. Global Pemetrexed Disodium for Injection Sales by Type (2027-2032) & (k units) Table 41. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2021-2026) Table 42. Global Pemetrexed Disodium for Injection Sales Market Share by Type (2027-2032) Table 43. Global Pemetrexed Disodium for Injection Price by Type (2021-2026) & (US$/unit) Table 44. Global Pemetrexed Disodium for Injection Price by Type (2027-2032) & (US$/unit) Table 45. Global Pemetrexed Disodium for Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Pemetrexed Disodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Pemetrexed Disodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2021-2026) Table 49. Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2027-2032) Table 50. Global Pemetrexed Disodium for Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 52. Global Pemetrexed Disodium for Injection Sales by Application (2027-2032) & (k units) Table 53. Global Pemetrexed Disodium for Injection Sales Market Share by Application (2021-2026) Table 54. Global Pemetrexed Disodium for Injection Sales Market Share by Application (2027-2032) Table 55. Global Pemetrexed Disodium for Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Pemetrexed Disodium for Injection Price by Application (2027-2032) & (US$/unit) Table 57. Accord Healthcare Company Information Table 58. Accord Healthcare Business Overview Table 59. Accord Healthcare Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio Table 61. Accord Healthcare Recent Development Table 62. Amneal Pharmaceuticals Company Information Table 63. Amneal Pharmaceuticals Business Overview Table 64. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio Table 66. Amneal Pharmaceuticals Recent Development Table 67. APOTEX Company Information Table 68. APOTEX Business Overview Table 69. APOTEX Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. APOTEX Pemetrexed Disodium for Injection Product Portfolio Table 71. APOTEX Recent Development Table 72. Biocon Company Information Table 73. Biocon Business Overview Table 74. Biocon Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Biocon Pemetrexed Disodium for Injection Product Portfolio Table 76. Biocon Recent Development Table 77. Dr. Reddy's Laboratories Company Information Table 78. Dr. Reddy's Laboratories Business Overview Table 79. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio Table 81. Dr. Reddy's Laboratories Recent Development Table 82. Eugia Pharma Company Information Table 83. Eugia Pharma Business Overview Table 84. Eugia Pharma Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio Table 86. Eugia Pharma Recent Development Table 87. Nang Kuang Pharmaceutical Company Information Table 88. Nang Kuang Pharmaceutical Business Overview Table 89. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 91. Nang Kuang Pharmaceutical Recent Development Table 92. Pfizer (Hospira) Company Information Table 93. Pfizer (Hospira) Business Overview Table 94. Pfizer (Hospira) Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio Table 96. Pfizer (Hospira) Recent Development Table 97. Waverley Pharma Company Information Table 98. Waverley Pharma Business Overview Table 99. Waverley Pharma Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio Table 101. Waverley Pharma Recent Development Table 102. Zydus Lifesciences Company Information Table 103. Zydus Lifesciences Business Overview Table 104. Zydus Lifesciences Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio Table 106. Zydus Lifesciences Recent Development Table 107. Baxter Company Information Table 108. Baxter Business Overview Table 109. Baxter Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Baxter Pemetrexed Disodium for Injection Product Portfolio Table 111. Baxter Recent Development Table 112. Beijing Xiehe Pharmaceutical Company Information Table 113. Beijing Xiehe Pharmaceutical Business Overview Table 114. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 116. Beijing Xiehe Pharmaceutical Recent Development Table 117. Dezhou Deyao Pharmaceutical Company Information Table 118. Dezhou Deyao Pharmaceutical Business Overview Table 119. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 121. Dezhou Deyao Pharmaceutical Recent Development Table 122. Fresenius Kabi Company Information Table 123. Fresenius Kabi Business Overview Table 124. Fresenius Kabi Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio Table 126. Fresenius Kabi Recent Development Table 127. Hainan Jinrui Pharmaceutical Company Information Table 128. Hainan Jinrui Pharmaceutical Business Overview Table 129. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 131. Hainan Jinrui Pharmaceutical Recent Development Table 132. Kelun Pharmaceutical Company Information Table 133. Kelun Pharmaceutical Business Overview Table 134. Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 136. Kelun Pharmaceutical Recent Development Table 137. Jiangsu Aosaikang Pharmaceutical Company Information Table 138. Jiangsu Aosaikang Pharmaceutical Business Overview Table 139. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 141. Jiangsu Aosaikang Pharmaceutical Recent Development Table 142. Qilu Pharmaceutical Company Information Table 143. Qilu Pharmaceutical Business Overview Table 144. Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 146. Qilu Pharmaceutical Recent Development Table 147. Lilly Company Information Table 148. Lilly Business Overview Table 149. Lilly Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 150. Lilly Pemetrexed Disodium for Injection Product Portfolio Table 151. Lilly Recent Development Table 152. Lianyungang Jaripharm Pharmaceutical Company Information Table 153. Lianyungang Jaripharm Pharmaceutical Business Overview Table 154. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 155. Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 156. Lianyungang Jaripharm Pharmaceutical Recent Development Table 157. Nanjing Pharmaceutical Factory Company Information Table 158. Nanjing Pharmaceutical Factory Business Overview Table 159. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 160. Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio Table 161. Nanjing Pharmaceutical Factory Recent Development Table 162. Jiangsu Hansoh Pharmaceutical Company Information Table 163. Jiangsu Hansoh Pharmaceutical Business Overview Table 164. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 165. Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 166. Jiangsu Hansoh Pharmaceutical Recent Development Table 167. Sandoz Company Information Table 168. Sandoz Business Overview Table 169. Sandoz Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 170. Sandoz Pemetrexed Disodium for Injection Product Portfolio Table 171. Sandoz Recent Development Table 172. Zhendong Group Company Information Table 173. Zhendong Group Business Overview Table 174. Zhendong Group Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 175. Zhendong Group Pemetrexed Disodium for Injection Product Portfolio Table 176. Zhendong Group Recent Development Table 177. Shanghai Chemo Wanbang Biopharma Company Information Table 178. Shanghai Chemo Wanbang Biopharma Business Overview Table 179. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 180. Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio Table 181. Shanghai Chemo Wanbang Biopharma Recent Development Table 182. Sichuan Huiyu Pharmaceutical Company Information Table 183. Sichuan Huiyu Pharmaceutical Business Overview Table 184. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 185. Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 186. Sichuan Huiyu Pharmaceutical Recent Development Table 187. Suzhou Erye Pharmaceutical Company Information Table 188. Suzhou Erye Pharmaceutical Business Overview Table 189. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 190. Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 191. Suzhou Erye Pharmaceutical Recent Development Table 192. Suzhou Thery Pharmaceutical Company Information Table 193. Suzhou Thery Pharmaceutical Business Overview Table 194. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 195. Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 196. Suzhou Thery Pharmaceutical Recent Development Table 197. Jiangsu Simcere Pharmaceutical Company Information Table 198. Jiangsu Simcere Pharmaceutical Business Overview Table 199. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 200. Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio Table 201. Jiangsu Simcere Pharmaceutical Recent Development Table 202. Yangtze River Pharmaceutical Group Company Information Table 203. Yangtze River Pharmaceutical Group Business Overview Table 204. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 205. Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio Table 206. Yangtze River Pharmaceutical Group Recent Development Table 207. North America Pemetrexed Disodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 208. North America Pemetrexed Disodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 209. North America Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 210. North America Pemetrexed Disodium for Injection Sales by Type (2027-2032) & (k units) Table 211. North America Pemetrexed Disodium for Injection Sales Price by Type (2021-2026) & (US$/unit) Table 212. North America Pemetrexed Disodium for Injection Sales Price by Type (2027-2032) & (US$/unit) Table 213. North America Pemetrexed Disodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 214. North America Pemetrexed Disodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 215. North America Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 216. North America Pemetrexed Disodium for Injection Sales by Application (2027-2032) & (k units) Table 217. North America Pemetrexed Disodium for Injection Sales Price by Application (2021-2026) & (US$/unit) Table 218. North America Pemetrexed Disodium for Injection Sales Price by Application (2027-2032) & (US$/unit) Table 219. North America Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 220. North America Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 221. North America Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 222. North America Pemetrexed Disodium for Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 223. North America Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 224. North America Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units) Table 225. North America Pemetrexed Disodium for Injection Sales Price by Country (2021-2026) & (US$/unit) Table 226. North America Pemetrexed Disodium for Injection Sales Price by Country (2027-2032) & (US$/unit) Table 227. United States Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 228. Canada Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 229. Mexico Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 230. Europe Pemetrexed Disodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 231. Europe Pemetrexed Disodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 232. Europe Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 233. Europe Pemetrexed Disodium for Injection Sales by Type (2027-2032) & (k units) Table 234. Europe Pemetrexed Disodium for Injection Sales Price by Type (2021-2026) & (US$/unit) Table 235. Europe Pemetrexed Disodium for Injection Sales Price by Type (2027-2032) & (US$/unit) Table 236. Europe Pemetrexed Disodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 237. Europe Pemetrexed Disodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 238. Europe Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 239. Europe Pemetrexed Disodium for Injection Sales by Application (2027-2032) & (k units) Table 240. Europe Pemetrexed Disodium for Injection Sales Price by Application (2021-2026) & (US$/unit) Table 241. Europe Pemetrexed Disodium for Injection Sales Price by Application (2027-2032) & (US$/unit) Table 242. Europe Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 243. Europe Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 244. Europe Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 245. Europe Pemetrexed Disodium for Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 246. Europe Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 247. Europe Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units) Table 248. Europe Pemetrexed Disodium for Injection Sales Price by Country (2021-2026) & (US$/unit) Table 249. Europe Pemetrexed Disodium for Injection Sales Price by Country (2027-2032) & (US$/unit) Table 250. Germany Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 251. France Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 252. U.K. Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 253. Italy Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 254. Russia Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 255. Spain Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 256. Netherlands Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 257. Switzerland Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 258. Sweden Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 259. Poland Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 260. China Pemetrexed Disodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 261. China Pemetrexed Disodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 262. China Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 263. China Pemetrexed Disodium for Injection Sales by Type (2027-2032) & (k units) Table 264. China Pemetrexed Disodium for Injection Sales Price by Type (2021-2026) & (US$/unit) Table 265. China Pemetrexed Disodium for Injection Sales Price by Type (2027-2032) & (US$/unit) Table 266. China Pemetrexed Disodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 267. China Pemetrexed Disodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 268. China Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 269. China Pemetrexed Disodium for Injection Sales by Application (2027-2032) & (k units) Table 270. China Pemetrexed Disodium for Injection Sales Price by Application (2021-2026) & (US$/unit) Table 271. China Pemetrexed Disodium for Injection Sales Price by Application (2027-2032) & (US$/unit) Table 272. Asia Pemetrexed Disodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 273. Asia Pemetrexed Disodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 274. Asia Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 275. Asia Pemetrexed Disodium for Injection Sales by Type (2027-2032) & (k units) Table 276. Asia Pemetrexed Disodium for Injection Sales Price by Type (2021-2026) & (US$/unit) Table 277. Asia Pemetrexed Disodium for Injection Sales Price by Type (2027-2032) & (US$/unit) Table 278. Asia Pemetrexed Disodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 279. Asia Pemetrexed Disodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 280. Asia Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 281. Asia Pemetrexed Disodium for Injection Sales by Application (2027-2032) & (k units) Table 282. Asia Pemetrexed Disodium for Injection Sales Price by Application (2021-2026) & (US$/unit) Table 283. Asia Pemetrexed Disodium for Injection Sales Price by Application (2027-2032) & (US$/unit) Table 284. Asia Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 285. Asia Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 286. Asia Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 287. Asia Pemetrexed Disodium for Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 288. Asia Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 289. Asia Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units) Table 290. Asia Pemetrexed Disodium for Injection Sales Price by Country (2021-2026) & (US$/unit) Table 291. Asia Pemetrexed Disodium for Injection Sales Price by Country (2027-2032) & (US$/unit) Table 292. Japan Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 293. South Korea Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 294. India Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 295. Australia Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 296. Taiwan Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 297. Southeast Asia Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 298. SAMEA Pemetrexed Disodium for Injection Revenue by Type (2021-2026) & (US$ Million) Table 299. SAMEA Pemetrexed Disodium for Injection Revenue by Type (2027-2032) & (US$ Million) Table 300. SAMEA Pemetrexed Disodium for Injection Sales by Type (2021-2026) & (k units) Table 301. SAMEA Pemetrexed Disodium for Injection Sales by Type (2027-2032) & (k units) Table 302. SAMEA Pemetrexed Disodium for Injection Sales Price by Type (2021-2026) & (US$/unit) Table 303. SAMEA Pemetrexed Disodium for Injection Sales Price by Type (2027-2032) & (US$/unit) Table 304. SAMEA Pemetrexed Disodium for Injection Revenue by Application (2021-2026) & (US$ Million) Table 305. SAMEA Pemetrexed Disodium for Injection Revenue by Application (2027-2032) & (US$ Million) Table 306. SAMEA Pemetrexed Disodium for Injection Sales by Application (2021-2026) & (k units) Table 307. SAMEA Pemetrexed Disodium for Injection Sales by Application (2027-2032) & (k units) Table 308. SAMEA Pemetrexed Disodium for Injection Sales Price by Application (2021-2026) & (US$/unit) Table 309. SAMEA Pemetrexed Disodium for Injection Sales Price by Application (2027-2032) & (US$/unit) Table 310. SAMEA Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 311. SAMEA Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 312. SAMEA Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 313. SAMEA Pemetrexed Disodium for Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 314. SAMEA Pemetrexed Disodium for Injection Sales by Country (2021-2026) & (k units) Table 315. SAMEA Pemetrexed Disodium for Injection Sales by Country (2027-2032) & (k units) Table 316. SAMEA Pemetrexed Disodium for Injection Sales Price by Country (2021-2026) & (US$/unit) Table 317. SAMEA Pemetrexed Disodium for Injection Sales Price by Country (2027-2032) & (US$/unit) Table 318. Brazil Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 319. Argentina Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 320. Chile Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 321. Colombia Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 322. Peru Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 323. Saudi Arabia Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 324. Israel Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 325. UAE Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 326. Turkey Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 327. Iran Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 328. Egypt Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Table 329. Key Raw Materials Table 330. Raw Materials Key Suppliers Table 331. Pemetrexed Disodium for Injection Distributors List Table 332. Pemetrexed Disodium for Injection Customers List Table 333. Research Programs/Design for This Report Table 334. Authors List of This Report Table 335. Secondary Sources Table 336. Primary Sources List of Figures Figure 1. Pemetrexed Disodium for Injection Image Figure 2. Global Pemetrexed Disodium for Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemetrexed Disodium for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 500mg/Pcs Image Figure 5. 100mg/Pcs Image Figure 6. Global Pemetrexed Disodium for Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pemetrexed Disodium for Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Others Image Figure 11. Global Pemetrexed Disodium for Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pemetrexed Disodium for Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Pemetrexed Disodium for Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Pemetrexed Disodium for Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Pemetrexed Disodium for Injection Sales (2021-2032) & (k units) Figure 17. Global Pemetrexed Disodium for Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Pemetrexed Disodium for Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Pemetrexed Disodium for Injection Sales YoY (2021-2032) & (k units) Figure 20. Europe Pemetrexed Disodium for Injection Sales YoY (2021-2032) & (k units) Figure 21. China Pemetrexed Disodium for Injection Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Pemetrexed Disodium for Injection Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Pemetrexed Dis

Scope & coverage.

Types
  • 500mg/Pcs
  • 100mg/Pcs
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Accord Healthcare
  • Amneal Pharmaceuticals
  • APOTEX
  • Biocon
  • Dr. Reddy's Laboratories
  • Eugia Pharma
  • Nang Kuang Pharmaceutical
  • Pfizer (Hospira)
  • Waverley Pharma
  • Zydus Lifesciences
  • Baxter
  • Beijing Xiehe Pharmaceutical
  • Dezhou Deyao Pharmaceutical
  • Fresenius Kabi
  • Hainan Jinrui Pharmaceutical
  • Kelun Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Qilu Pharmaceutical
  • Lilly
  • Lianyungang Jaripharm Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Jiangsu Hansoh Pharmaceutical
  • Sandoz
  • Zhendong Group
  • Shanghai Chemo Wanbang Biopharma
  • Sichuan Huiyu Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • Suzhou Thery Pharmaceutical
  • Jiangsu Simcere Pharmaceutical
  • Yangtze River Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pemetrexed Disodium for Injection Market by Type
  3. 1.2.1 Global Pemetrexed Disodium for Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 500mg/Pcs
  5. 1.2.3 100mg/Pcs
  6. 1.3 Pemetrexed Disodium for Injection Market by Application
  7. 1.3.1 Global Pemetrexed Disodium for Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pemetrexed Disodium for Injection Market Dynamics
  1. 2.1 Pemetrexed Disodium for Injection Industry Trends
  2. 2.2 Pemetrexed Disodium for Injection Industry Drivers
  3. 2.3 Pemetrexed Disodium for Injection Industry Opportunities and Challenges
  4. 2.4 Pemetrexed Disodium for Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pemetrexed Disodium for Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pemetrexed Disodium for Injection Revenue by Region
  3. 3.2.1 Global Pemetrexed Disodium for Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pemetrexed Disodium for Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Pemetrexed Disodium for Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Pemetrexed Disodium for Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pemetrexed Disodium for Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pemetrexed Disodium for Injection Sales by Region
  9. 3.4.1 Global Pemetrexed Disodium for Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pemetrexed Disodium for Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Pemetrexed Disodium for Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Pemetrexed Disodium for Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pemetrexed Disodium for Injection Revenue by Manufacturers
  2. 4.1.1 Global Pemetrexed Disodium for Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pemetrexed Disodium for Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pemetrexed Disodium for Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pemetrexed Disodium for Injection Sales by Manufacturers
  6. 4.2.1 Global Pemetrexed Disodium for Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pemetrexed Disodium for Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pemetrexed Disodium for Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pemetrexed Disodium for Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pemetrexed Disodium for Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pemetrexed Disodium for Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pemetrexed Disodium for Injection Manufacturers, Product Type & Application
  13. 4.7 Global Pemetrexed Disodium for Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pemetrexed Disodium for Injection Market CR5 and HHI
  16. 4.8.2 2025 Pemetrexed Disodium for Injection Tier 1, Tier 2, and Tier 3
5 Pemetrexed Disodium for Injection Market by Type
  1. 5.1 Global Pemetrexed Disodium for Injection Revenue by Type
  2. 5.1.1 Global Pemetrexed Disodium for Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pemetrexed Disodium for Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pemetrexed Disodium for Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pemetrexed Disodium for Injection Sales by Type
  6. 5.2.1 Global Pemetrexed Disodium for Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pemetrexed Disodium for Injection Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Pemetrexed Disodium for Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pemetrexed Disodium for Injection Price by Type
6 Pemetrexed Disodium for Injection Market by Application
  1. 6.1 Global Pemetrexed Disodium for Injection Revenue by Application
  2. 6.1.1 Global Pemetrexed Disodium for Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pemetrexed Disodium for Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pemetrexed Disodium for Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pemetrexed Disodium for Injection Sales by Application
  6. 6.2.1 Global Pemetrexed Disodium for Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pemetrexed Disodium for Injection Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Pemetrexed Disodium for Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pemetrexed Disodium for Injection Price by Application
7 Company Profiles
  1. 7.1 Accord Healthcare
  2. 7.1.1 Accord Healthcare Company Information
  3. 7.1.2 Accord Healthcare Business Overview
  4. 7.1.3 Accord Healthcare Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Accord Healthcare Pemetrexed Disodium for Injection Product Portfolio
  6. 7.1.5 Accord Healthcare Recent Developments
  7. 7.2 Amneal Pharmaceuticals
  8. 7.2.1 Amneal Pharmaceuticals Company Information
  9. 7.2.2 Amneal Pharmaceuticals Business Overview
  10. 7.2.3 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Amneal Pharmaceuticals Pemetrexed Disodium for Injection Product Portfolio
  12. 7.2.5 Amneal Pharmaceuticals Recent Developments
  13. 7.3 APOTEX
  14. 7.3.1 APOTEX Company Information
  15. 7.3.2 APOTEX Business Overview
  16. 7.3.3 APOTEX Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 APOTEX Pemetrexed Disodium for Injection Product Portfolio
  18. 7.3.5 APOTEX Recent Developments
  19. 7.4 Biocon
  20. 7.4.1 Biocon Company Information
  21. 7.4.2 Biocon Business Overview
  22. 7.4.3 Biocon Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Biocon Pemetrexed Disodium for Injection Product Portfolio
  24. 7.4.5 Biocon Recent Developments
  25. 7.5 Dr. Reddy's Laboratories
  26. 7.5.1 Dr. Reddy's Laboratories Company Information
  27. 7.5.2 Dr. Reddy's Laboratories Business Overview
  28. 7.5.3 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Dr. Reddy's Laboratories Pemetrexed Disodium for Injection Product Portfolio
  30. 7.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 7.6 Eugia Pharma
  32. 7.6.1 Eugia Pharma Company Information
  33. 7.6.2 Eugia Pharma Business Overview
  34. 7.6.3 Eugia Pharma Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eugia Pharma Pemetrexed Disodium for Injection Product Portfolio
  36. 7.6.5 Eugia Pharma Recent Developments
  37. 7.7 Nang Kuang Pharmaceutical
  38. 7.7.1 Nang Kuang Pharmaceutical Company Information
  39. 7.7.2 Nang Kuang Pharmaceutical Business Overview
  40. 7.7.3 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nang Kuang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  42. 7.7.5 Nang Kuang Pharmaceutical Recent Developments
  43. 7.8 Pfizer (Hospira)
  44. 7.8.1 Pfizer (Hospira) Company Information
  45. 7.8.2 Pfizer (Hospira) Business Overview
  46. 7.8.3 Pfizer (Hospira) Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer (Hospira) Pemetrexed Disodium for Injection Product Portfolio
  48. 7.8.5 Pfizer (Hospira) Recent Developments
  49. 7.9 Waverley Pharma
  50. 7.9.1 Waverley Pharma Company Information
  51. 7.9.2 Waverley Pharma Business Overview
  52. 7.9.3 Waverley Pharma Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Waverley Pharma Pemetrexed Disodium for Injection Product Portfolio
  54. 7.9.5 Waverley Pharma Recent Developments
  55. 7.10 Zydus Lifesciences
  56. 7.10.1 Zydus Lifesciences Company Information
  57. 7.10.2 Zydus Lifesciences Business Overview
  58. 7.10.3 Zydus Lifesciences Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Zydus Lifesciences Pemetrexed Disodium for Injection Product Portfolio
  60. 7.10.5 Zydus Lifesciences Recent Developments
  61. 7.11 Baxter
  62. 7.11.1 Baxter Company Information
  63. 7.11.2 Baxter Business Overview
  64. 7.11.3 Baxter Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Baxter Pemetrexed Disodium for Injection Product Portfolio
  66. 7.11.5 Baxter Recent Developments
  67. 7.12 Beijing Xiehe Pharmaceutical
  68. 7.12.1 Beijing Xiehe Pharmaceutical Company Information
  69. 7.12.2 Beijing Xiehe Pharmaceutical Business Overview
  70. 7.12.3 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Beijing Xiehe Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  72. 7.12.5 Beijing Xiehe Pharmaceutical Recent Developments
  73. 7.13 Dezhou Deyao Pharmaceutical
  74. 7.13.1 Dezhou Deyao Pharmaceutical Company Information
  75. 7.13.2 Dezhou Deyao Pharmaceutical Business Overview
  76. 7.13.3 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Dezhou Deyao Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  78. 7.13.5 Dezhou Deyao Pharmaceutical Recent Developments
  79. 7.14 Fresenius Kabi
  80. 7.14.1 Fresenius Kabi Company Information
  81. 7.14.2 Fresenius Kabi Business Overview
  82. 7.14.3 Fresenius Kabi Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Fresenius Kabi Pemetrexed Disodium for Injection Product Portfolio
  84. 7.14.5 Fresenius Kabi Recent Developments
  85. 7.15 Hainan Jinrui Pharmaceutical
  86. 7.15.1 Hainan Jinrui Pharmaceutical Company Information
  87. 7.15.2 Hainan Jinrui Pharmaceutical Business Overview
  88. 7.15.3 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Hainan Jinrui Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  90. 7.15.5 Hainan Jinrui Pharmaceutical Recent Developments
  91. 7.16 Kelun Pharmaceutical
  92. 7.16.1 Kelun Pharmaceutical Company Information
  93. 7.16.2 Kelun Pharmaceutical Business Overview
  94. 7.16.3 Kelun Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Kelun Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  96. 7.16.5 Kelun Pharmaceutical Recent Developments
  97. 7.17 Jiangsu Aosaikang Pharmaceutical
  98. 7.17.1 Jiangsu Aosaikang Pharmaceutical Company Information
  99. 7.17.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  100. 7.17.3 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Jiangsu Aosaikang Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  102. 7.17.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  103. 7.18 Qilu Pharmaceutical
  104. 7.18.1 Qilu Pharmaceutical Company Information
  105. 7.18.2 Qilu Pharmaceutical Business Overview
  106. 7.18.3 Qilu Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Qilu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  108. 7.18.5 Qilu Pharmaceutical Recent Developments
  109. 7.19 Lilly
  110. 7.19.1 Lilly Company Information
  111. 7.19.2 Lilly Business Overview
  112. 7.19.3 Lilly Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Lilly Pemetrexed Disodium for Injection Product Portfolio
  114. 7.19.5 Lilly Recent Developments
  115. 7.20 Lianyungang Jaripharm Pharmaceutical
  116. 7.20.1 Lianyungang Jaripharm Pharmaceutical Company Information
  117. 7.20.2 Lianyungang Jaripharm Pharmaceutical Business Overview
  118. 7.20.3 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Lianyungang Jaripharm Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  120. 7.20.5 Lianyungang Jaripharm Pharmaceutical Recent Developments
  121. 7.21 Nanjing Pharmaceutical Factory
  122. 7.21.1 Nanjing Pharmaceutical Factory Company Information
  123. 7.21.2 Nanjing Pharmaceutical Factory Business Overview
  124. 7.21.3 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  125. 7.21.4 Nanjing Pharmaceutical Factory Pemetrexed Disodium for Injection Product Portfolio
  126. 7.21.5 Nanjing Pharmaceutical Factory Recent Developments
  127. 7.22 Jiangsu Hansoh Pharmaceutical
  128. 7.22.1 Jiangsu Hansoh Pharmaceutical Company Information
  129. 7.22.2 Jiangsu Hansoh Pharmaceutical Business Overview
  130. 7.22.3 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  131. 7.22.4 Jiangsu Hansoh Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  132. 7.22.5 Jiangsu Hansoh Pharmaceutical Recent Developments
  133. 7.23 Sandoz
  134. 7.23.1 Sandoz Company Information
  135. 7.23.2 Sandoz Business Overview
  136. 7.23.3 Sandoz Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  137. 7.23.4 Sandoz Pemetrexed Disodium for Injection Product Portfolio
  138. 7.23.5 Sandoz Recent Developments
  139. 7.24 Zhendong Group
  140. 7.24.1 Zhendong Group Company Information
  141. 7.24.2 Zhendong Group Business Overview
  142. 7.24.3 Zhendong Group Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  143. 7.24.4 Zhendong Group Pemetrexed Disodium for Injection Product Portfolio
  144. 7.24.5 Zhendong Group Recent Developments
  145. 7.25 Shanghai Chemo Wanbang Biopharma
  146. 7.25.1 Shanghai Chemo Wanbang Biopharma Company Information
  147. 7.25.2 Shanghai Chemo Wanbang Biopharma Business Overview
  148. 7.25.3 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  149. 7.25.4 Shanghai Chemo Wanbang Biopharma Pemetrexed Disodium for Injection Product Portfolio
  150. 7.25.5 Shanghai Chemo Wanbang Biopharma Recent Developments
  151. 7.26 Sichuan Huiyu Pharmaceutical
  152. 7.26.1 Sichuan Huiyu Pharmaceutical Company Information
  153. 7.26.2 Sichuan Huiyu Pharmaceutical Business Overview
  154. 7.26.3 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  155. 7.26.4 Sichuan Huiyu Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  156. 7.26.5 Sichuan Huiyu Pharmaceutical Recent Developments
  157. 7.27 Suzhou Erye Pharmaceutical
  158. 7.27.1 Suzhou Erye Pharmaceutical Company Information
  159. 7.27.2 Suzhou Erye Pharmaceutical Business Overview
  160. 7.27.3 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  161. 7.27.4 Suzhou Erye Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  162. 7.27.5 Suzhou Erye Pharmaceutical Recent Developments
  163. 7.28 Suzhou Thery Pharmaceutical
  164. 7.28.1 Suzhou Thery Pharmaceutical Company Information
  165. 7.28.2 Suzhou Thery Pharmaceutical Business Overview
  166. 7.28.3 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  167. 7.28.4 Suzhou Thery Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  168. 7.28.5 Suzhou Thery Pharmaceutical Recent Developments
  169. 7.29 Jiangsu Simcere Pharmaceutical
  170. 7.29.1 Jiangsu Simcere Pharmaceutical Company Information
  171. 7.29.2 Jiangsu Simcere Pharmaceutical Business Overview
  172. 7.29.3 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  173. 7.29.4 Jiangsu Simcere Pharmaceutical Pemetrexed Disodium for Injection Product Portfolio
  174. 7.29.5 Jiangsu Simcere Pharmaceutical Recent Developments
  175. 7.30 Yangtze River Pharmaceutical Group
  176. 7.30.1 Yangtze River Pharmaceutical Group Company Information
  177. 7.30.2 Yangtze River Pharmaceutical Group Business Overview
  178. 7.30.3 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  179. 7.30.4 Yangtze River Pharmaceutical Group Pemetrexed Disodium for Injection Product Portfolio
  180. 7.30.5 Yangtze River Pharmaceutical Group Recent Developments
8 North America
  1. 8.1 North America Pemetrexed Disodium for Injection Market Size by Type
  2. 8.1.1 North America Pemetrexed Disodium for Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Pemetrexed Disodium for Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Pemetrexed Disodium for Injection Price by Type (2021-2032)
  5. 8.2 North America Pemetrexed Disodium for Injection Market Size by Application
  6. 8.2.1 North America Pemetrexed Disodium for Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Pemetrexed Disodium for Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Pemetrexed Disodium for Injection Price by Application (2021-2032)
  9. 8.3 North America Pemetrexed Disodium for Injection Market Size by Country
  10. 8.3.1 North America Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pemetrexed Disodium for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pemetrexed Disodium for Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pemetrexed Disodium for Injection Market Size by Type
  2. 9.1.1 Europe Pemetrexed Disodium for Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pemetrexed Disodium for Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Pemetrexed Disodium for Injection Price by Type (2021-2032)
  5. 9.2 Europe Pemetrexed Disodium for Injection Market Size by Application
  6. 9.2.1 Europe Pemetrexed Disodium for Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pemetrexed Disodium for Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Pemetrexed Disodium for Injection Price by Application (2021-2032)
  9. 9.3 Europe Pemetrexed Disodium for Injection Market Size by Country
  10. 9.3.1 Europe Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pemetrexed Disodium for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pemetrexed Disodium for Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pemetrexed Disodium for Injection Market Size by Type
  2. 10.1.1 China Pemetrexed Disodium for Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Pemetrexed Disodium for Injection Sales by Type (2021-2032)
  4. 10.1.3 China Pemetrexed Disodium for Injection Price by Type (2021-2032)
  5. 10.2 China Pemetrexed Disodium for Injection Market Size by Application
  6. 10.2.1 China Pemetrexed Disodium for Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Pemetrexed Disodium for Injection Sales by Application (2021-2032)
  8. 10.2.3 China Pemetrexed Disodium for Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pemetrexed Disodium for Injection Market Size by Type
  2. 11.1.1 Asia Pemetrexed Disodium for Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pemetrexed Disodium for Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Pemetrexed Disodium for Injection Price by Type (2021-2032)
  5. 11.2 Asia Pemetrexed Disodium for Injection Market Size by Application
  6. 11.2.1 Asia Pemetrexed Disodium for Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pemetrexed Disodium for Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Pemetrexed Disodium for Injection Price by Application (2021-2032)
  9. 11.3 Asia Pemetrexed Disodium for Injection Market Size by Country
  10. 11.3.1 Asia Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pemetrexed Disodium for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pemetrexed Disodium for Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pemetrexed Disodium for Injection Market Size by Type
  2. 12.1.1 SAMEA Pemetrexed Disodium for Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pemetrexed Disodium for Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pemetrexed Disodium for Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Pemetrexed Disodium for Injection Market Size by Application
  6. 12.2.1 SAMEA Pemetrexed Disodium for Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pemetrexed Disodium for Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pemetrexed Disodium for Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Pemetrexed Disodium for Injection Market Size by Country
  10. 12.3.1 SAMEA Pemetrexed Disodium for Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pemetrexed Disodium for Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pemetrexed Disodium for Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pemetrexed Disodium for Injection Value Chain Analysis
  2. 13.1.1 Pemetrexed Disodium for Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pemetrexed Disodium for Injection Production Mode & Process
  6. 13.2 Pemetrexed Disodium for Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pemetrexed Disodium for Injection Distributors
  9. 13.2.3 Pemetrexed Disodium for Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst